A simultaneous assay method using capillary zone electrophoresis for a fixed dose combination of vildagliptin and metformin hydrochloride in coated tablets

Competitive CE-UV binding tests for selective recognition of bisphenol A by molecularly imprinted polymer particles

(2012) Samar Alsudir et al.   ELECTROPHORESIS

Stability-Indicating RP-LC Method for the Determination of Vildagliptin and Mass Spectrometry Detection for a Main Degradation Product

(2012) A. T. Barden et al.   JOURNAL OF CHROMATOGRAPHIC SCIENCE

Determination of rosiglitazone and metformin in human serum by CE-ESI-MS

(2011) Joanna Znaleziona et al.   JOURNAL OF SEPARATION SCIENCE

Determination of metformin hydrochloride using precolumn derivatization with acetaldehyde and capillary electrophoresis coupled with electrochemiluminescence

(2011) Biyang Deng et al.   LUMINESCENCE

New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser

(2010) Y. M. Cho et al.   DIABETOLOGIA

Development and validation of a stability indicating capillary electrophoresis method for the determination of metformin hydrochloride in tablets

(2010) I.I. Hamdan et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin

(2009) G. Bolli et al.   DIABETES OBESITY & METABOLISM

Translating science into clinical practice: focus on vildagliptin in combination with metformin

(2009) A. H. Barnett   DIABETES OBESITY & METABOLISM

Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus

(2009) E. Bosi et al.   DIABETES OBESITY & METABOLISM

Global estimates of the prevalence of diabetes for 2010 and 2030

(2009) J.E. Shaw et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Development and validation of an analytical method for metformin hydrochloride and its related compound (1-cyanoguanidine) in tablet formulations by HPLC-UV

(2009) F. Al-Rimawi   TALANTA

Efficacy and tolerability of vildagliptin in drug-nave patients with type 2 diabetes and mild hyperglycaemia

(2008) W. A. Scherbaum et al.   DIABETES OBESITY & METABOLISM

Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea*

(2008) A. J. Garber et al.   DIABETES OBESITY & METABOLISM

Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial

(2008) C. Pan et al.   DIABETIC MEDICINE